Cosmos Holdings (COSM) Announces Application for Dual Listing on Upstream
Get instant notifications when there’s news about your stocks. Claim your 1 week free trial StreetInsider Premium here.
Cosmos Health Inc. (Nasdaq:COSM)a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC drugs and medical devices, announced today that it has completed the application process for the dual listing of its shares on Upstream, the trading app for digital securities and NFTs, started by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”).
The proposed dual listing on Upstream is intended to give Cosmos Health the opportunity to access a global, digitally-focused investor base that can trade the USDC digital currency along with credit, debit, PayPal and USD, thereby increasing liquidity and pricing with globalization enhancing the opportunity to invest in NASDAQ-listed Cosmos Health.
“Our application process at Upstream is another avenue we are exploring to increase the liquidity of our shares by attracting international investors and ultimately increasing shareholder value.” explained Greg Siokas, Chief Executive Officer of Cosmos Health. “Given the global and innovative nature of our brands and products, it is important that we reach a global audience of investors who are not constrained by geographic or currency parameters, and Upstream is an important medium in this endeavor.”
Approval to be listed on Upstream is subject to acceptance by MERJ. However, as an existing NASDAQ issuer, Cosmos Health may qualify for an expedited listing process.
Upstream, a MERJ Exchange Market (merj.exchange), is a fully regulated global exchange for digital securities and NFTs. Powered by Horizon’s proprietary matching engine technology, the platform enables users to trade digital securities and NFTs, and with the upstream app, securities for IPOs, crowdfunding firms, US and international stocks, and celebrity ventures to invest. For more information, see https://upstream.exchange.
Cosmos Health Inc. (Nasdaq: COSM) is a global healthcare company founded in 2009 and headquartered in Chicago, Illinois. Cosmos Health operates in the nutraceutical sector through its own proprietary product lines Sky Premium Life and Mediterraneanation. In addition, the Company is active in the pharmaceutical sector by offering a wide range of branded generic and OTC medicines and is active in the healthcare distribution sector through its subsidiaries in Greece and the UK which supply retail pharmacies and wholesalers. Cosmos Health is strategically focused on the research and development of novel patented nutraceuticals (IP) and specialty root extracts, as well as the research and development of proprietary complex generics and innovative OTC products. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Health has offices and distribution centers in Thessaloniki and Athens, Greece and Harlow, UK. For more information, see www.cosmosholdingsinc.com and www.skypremiumlife.com.